Return to program book search
Pediatric Psoriasis: Systemic Therapy and Beyond
Sunday, March 23
Mile High Ballroom 3B
3:30 PM - 5:30 PM
Kelly M. Cordoro, MD, FAAD
- Wilson Liao, MD, FAAD
- Amy S. Paller, MD, FAAD
- Megha M. Tollefson, MD, FAAD
Following this course, the attendee should be able to:
- Describe the genetics of pediatric psoriasis and its clinical relevance.
- Evaluate patients for potential comorbidities of pediatric psoriasis.
- Select the most appropriate systemic, biologic and light-based treatments for moderate to severe pediatric psoriasis.
The management of moderate to severe pediatric psoriasis can be challenging and requires a current understanding of the potential metabolic and psychosocial comorbidities and safety and efficacy of commonly used therapies in this age group. This session will update the clinician on the most recent genetic, epidemiologic, and comorbid data as well as discuss the basic principles and advanced practices necessary to treat moderate to severe psoriasis in children. Experts will discuss each of these areas and there will be plenty of time for audience questions. The session is directed towards practicing clinicians and residents and is intended to be immediately applicable to your practice.
|Sunday, March 23|
|3:30 PM||Introduction and Session Description / Dr. Cordoro|
|3:35 PM||Clinically Relevant Genetics of Pediatric Psoriasis / Dr. Liao|
|3:55 PM||Comorbidities of Pediatric Psoriasis and the Role of Biologic Therapy in Children with Psoriasis- Where Are We Now? / Dr. Paller|
|4:25 PM||Phototherapy for Pediatric Psoriasis: Practical Pearls from the Mayo Clinic / Dr. Tollefson|
|4:45 PM||Oldies but Goodies: Conventional Systemic Therapy for Pediatric Psoriasis / Dr. Cordoro|
|5:15 PM||Questions from the Audience and Closing Remarks / All faculty|